Mobile Trading

NATURAL CAPSULES LTD.

NSE : NABSE : 524654ISIN CODE : INE936B01015Industry : Pharmaceuticals & DrugsHouse : Private
BSE334.70-1.65 (-0.49 %)
PREV CLOSE ( ) 336.35
OPEN PRICE ( ) 334.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 8225
TODAY'S LOW / HIGH ( )331.00 343.40
52 WK LOW / HIGH ( ) 295479.8
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1993
Management Info
C P Rangachar - Chairman Sunil L Mundra - Managing Director
Registered Office

Address Trident Towers,4th Floor, No. 23, 100 Feet Road,Jaynagar I I Block,
Bengaluru,
Karnataka-560011

Phone 080- 26561562 / 1571 / 1573 / 581

Email info@naturalcapsules.com / company.sec@naturalcapsules.com

Website www.naturalcapsules.com

Registrars Details
Cameo Corporate Services Ltd
Subramanian Buildings No 1 ,Club House Road,,Chennai
Listing : BSE
NEWS
02May Announcement Under Regulation 30(LODR
Pursuant to Regulation 30, SEBI (LODR), we would like to inform you that..
24Apr Natural Capsules informs about loss of
Natural Capsules has informed that shareholders have been issued duplica..
18Jan Natural Capsules informs about loss of
Pursuant to Regulation 39(3) of SEBI (Listing obligations & Disclosu..
10Nov Natural Capsules informs about press r
Pursuant to Regulation 30 of Securities and Exchange Board of India (Lis..
30Sep Natural Capsules, its arm enter into a
Natural Capsules and its subsidiary -- Natural Biogenex have entered int..
Financials
in Millions
QTR Dec 23 ANNUAL 23
Net Profit17191.9
Gross Profit 22.9 257.4
Operating Profit 56.5365
Net Sales 383.81728.7
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Ajanta Pharma (BSE)
up  2377.00 (6.44%)
M.Cap ( in Cr)29930.39
Alkem Laboratories (BSE)
up  4899.45 (2.36%)
M.Cap ( in Cr)58580.27
Astrazeneca Pharma I (BSE)
up  5424.45 (1.70%)
M.Cap ( in Cr)13561.13
Dr. Reddy's Lab (BSE)
up  6349.95 (0.98%)
M.Cap ( in Cr)105928.76
Torrent Pharma (BSE)
up  2732.60 (2.20%)
M.Cap ( in Cr)92483.60
Shareholding Pattern
PROMOTERS 56.56%
NON-INSTITUTION 42.13%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holdings
Scheme NameHold(%)
No Data Found
  • attention investors
  • kyc
  • ipo
  • ibt trading

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
© 2018 Ratnakar Securities Pvt. Ltd. All rights reserved.
Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.